Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Gene mutations can cause problems in male genital development.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

New genes and pathways are important for testosterone production and male sexual development.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

New treatments for PCOS focus on managing symptoms and improving fertility.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Moderately high prolactin levels do not cause hair loss in women.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).